Generics Pharmaceutical Industry in Spain
May 2011: Generics Pharmaceutical Industry in Spain
The cost of healthcare in the developed countries is increasing and the recent economic recession has put a strong financial pressure on the healthcare expenditures in many of these developed countries. Though it is the fourth largest market in EU5, Spanish market for generic medicines is underdeveloped compared to its European counterparts. The high growth rate of close to 20% CAGR along with the pro-generic policies of the Spanish Government also provides huge opportunities for the generic companies.